Health-related quality of life in autoimmune hepatitis

R.J.A.L.M. Snijders, P. Milkiewicz, C. Schramm, T.J.G. Gevers*

*Corresponding author for this work

Research output: Contribution to journal(Systematic) Review article peer-review

Abstract

Autoimmune hepatitis (AIH) is a severe chronic autoimmune disease and has a significant impact on the patient's quality of life, in particular regarding psychological problems such as anxiety and depression. Consistent evidence on which patient-related, disease-related or physician-related factors cause health-related quality of life (HRQoL) impairment in patients with AIH is lacking. Current studies on HRQoL in AIH are mainly single-centered, comprising small numbers of patients, and difficult to compare because of the use of different questionnaires, patient populations, and cutoff values. Literature in the pediatric field is sparse, but suggests that children/adolescents with AIH have a lower HRQoL. Knowledge of HRQoL and cohesive factors in AIH are important to improve healthcare for AIH patients, for example by developing an AIH-specific chronic healthcare model. By recognizing the importance of quality of life beyond the concept of biochemical and histological remission, clinicians allow us to seek enhancements and possible interventions in the management of AIH, aiming at improved health.
Original languageEnglish
Pages (from-to)1642-1652
Number of pages11
JournalWorld Journal of Hepatology
Volume13
Issue number11
DOIs
Publication statusPublished - 27 Nov 2021

Keywords

  • Autoimmune hepatitis
  • Quality of life
  • Depression
  • Anxiety
  • Corticosteroids
  • DEPRESSION
  • DISEASE
  • VALIDATION
  • ANXIETY
  • IMPACT
  • FATIGUE
  • QUESTIONNAIRE
  • ADOLESCENTS
  • MALIGNANCY
  • MANAGEMENT

Fingerprint

Dive into the research topics of 'Health-related quality of life in autoimmune hepatitis'. Together they form a unique fingerprint.

Cite this